TAMPA, October 2, 2017 – Biomedical test equipment specialist Rigel Medical has launched its latest electrical safety analyzer in the USA, which is ideal for the testing of medical and laboratory equipment.
The SafeTest 99 offers accurate, high-current, low-energy ground continuity testing to provide users with fast and precise readings, with tests carried out in accordance with NFPA 99 guidelines.
Correct results are always achieved due to an automatic warning of secondary ground paths, eliminating the opportunity for invalid readings.
The SafeTest 99 is compact, portable and easy to use, with an intuitive layout and a fast selection of test routines.
Testing is simple and quick to do, while full manual control allows the user to select specific required tests.
Jack Barrett, National Business Development Manager at Rigel Medical (soon to be Seaward Medical), said: “The SafeTest 99 further expands the ever-popular SafeTest product line with an economical solution to electrical safety testing.”
The device performs electrical safety tests including point-to-point testing, load current measurement, ground leakage, chassis (also known as touch) leakage, patient lead leakage and ground continuity.
Andrew Upton, Managing Director at Seaward Group, Rigel Medical’s parent company, said: “We’ve developed a medical safety analyzer that can be used both for medical and laboratory equipment, at line voltages ranging from 90 to 264vac with patient lead testing.
“We want to make sure patients receive the highest level of care and Rigel Medical is pleased to play an integral role in keeping medical equipment safe.”
Rigel Medical, with offices located in Peterlee, England and Tampa, Florida, is one of the medical industry’s longest established manufacturers. The firm dates back to the 1970s when it created the world’s first electrical safety analyzer.
Seaward Group is the UK’s leading manufacturer of electrical safety test equipment and is celebrating more than 35 years of keeping people safe.
Register now for a free online product demonstration of the SafeTest 99 at www.rigelmedical.com/safetest99
The SafeTest 99 offers accurate, high-current, low-energy ground continuity testing to provide users with fast and precise readings, with tests carried out in accordance with NFPA 99 guidelines.
Correct results are always achieved due to an automatic warning of secondary ground paths, eliminating the opportunity for invalid readings.
The SafeTest 99 is compact, portable and easy to use, with an intuitive layout and a fast selection of test routines.
Testing is simple and quick to do, while full manual control allows the user to select specific required tests.
Jack Barrett, National Business Development Manager at Rigel Medical (soon to be Seaward Medical), said: “The SafeTest 99 further expands the ever-popular SafeTest product line with an economical solution to electrical safety testing.”
The device performs electrical safety tests including point-to-point testing, load current measurement, ground leakage, chassis (also known as touch) leakage, patient lead leakage and ground continuity.
Andrew Upton, Managing Director at Seaward Group, Rigel Medical’s parent company, said: “We’ve developed a medical safety analyzer that can be used both for medical and laboratory equipment, at line voltages ranging from 90 to 264vac with patient lead testing.
“We want to make sure patients receive the highest level of care and Rigel Medical is pleased to play an integral role in keeping medical equipment safe.”
Rigel Medical, with offices located in Peterlee, England and Tampa, Florida, is one of the medical industry’s longest established manufacturers. The firm dates back to the 1970s when it created the world’s first electrical safety analyzer.
Seaward Group is the UK’s leading manufacturer of electrical safety test equipment and is celebrating more than 35 years of keeping people safe.
Register now for a free online product demonstration of the SafeTest 99 at www.rigelmedical.com/safetest99